Cargando…
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
Background: The impact of biologics on the risk of postoperative complications (PC) in inflammatory bowel disease (IBD) is still an ongoing debate. This lack of evidence is more relevant for ustekinumab and vedolizumab. Aims: To evaluate the impact of biologics on the risk of PC. Methods: A retrospe...
Ejemplares similares
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
por: Rubín de Célix, Cristina, et al.
Publicado: (2023) -
Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG()
por: Crespo, Javier, et al.
Publicado: (2020) -
Employee Engagement and Wellbeing in Times of COVID-19: A Proposal of the 5Cs Model
por: De-la-Calle-Durán, María-Carmen, et al.
Publicado: (2021) -
Restablecimiento de la actividad en los servicios de Digestivo. Recomendaciones de la SEPD, AEEH, GETECCU y AEG()
por: Crespo, Javier, et al.
Publicado: (2020) -
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience
por: Barreiro‐de Acosta, Manuel, et al.
Publicado: (2021)